Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Aridis Pharmaceuticals, Inc.

(Updated) Aridis Pharmaceuticals Receives Equity Investment from the Cystic Fibrosis Foundation
From Aridis Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers ARDS
Aridis Pharmaceuticals Receives Equity Investment from the Cystic Fibrosis Foundation
From Aridis Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers ARDS
Aridis Signs Exclusive Terms to Secure Worldwide Commercial Licenses for Pan-Ebola and Pan-Marburg Monoclonal Antibody Programs from Mapp Biopharmaceutical
From Aridis Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers ARDS
Aridis Announces a Key Milestone of Closing of Patient Enrollment in the Phase 2a Study of AR-501 in Cystic Fibrosis Patients
From Aridis Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers ARDS
Aridis to Participate in Key Opinion Leader Discussion on Immunotherapy for Infectious Diseases
From Aridis Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers ARDS
Aridis Pharmaceuticals Announces Third Quarter 2022 Financial Results and Business Update
From Aridis Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers ARDS
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.